MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Cure Cancer Australia Foundation (APP1122758)
- Cancer Institute NSW (CDF181166)
- Cancer Institute NSW (2020/TPG2100)
- Cancer Institute NSW (2021/CBG0003)
- National Health and Medical Research Council (APP2002707)
- PanKind, The Australian Pancreatic Cancer Foundation
This publication has 46 references indexed in Scilit:
- A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in VivoBiomacromolecules, 2016
- Oxaliplatin-induced Oxidative Stress Provokes Toxicity in Isolated Rat Liver MitochondriaArchives of Medical Research, 2015
- Mammalian MutY homolog (MYH or MUTYH) protects cells from oxidative DNA damageDNA Repair, 2014
- γH2AX: a sensitive molecular marker of DNA damage and repairLeukemia, 2010
- Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanateCancer Cell, 2006
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Efficiency, specificity and DNA polymerase-dependence of translesion replication across the oxidative DNA lesion 8-oxoguanine in human cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
- Identification, culture, and characterization of pancreatic stellate cells in rats and humansGastroenterology, 1998
- MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesisNature, 1992
- Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodGNature, 1991